On December 7, 2001, the U.S. Food and Drug Administration told Bristol-Myers Squibb Co. that it must include a "Black Box" warning on all Serzone labels, informing patients about life-threatening liver damages that can occur when using Serzone. The FDA required the warning to advise that patients could suffer from liver failure, leading to death or the need for a liver transplant. In addition to warning labels, Serzone patients will also be provided with patient insert warnings. Bristol-Myers Squibb has also been ordered to issue a letter to doctors warning about potential liver failure.
If you or someone you know is taking Serzone and have experienced liver damage you may be entitled to compensation. Contact us for legal consultationGet Legal Help | Serzone Facts | Serzone Liver Damage | Serzone FDA Warnings | Home
Serzone Liver Damage Lawsuits is sponsored by affiliated law firms throughout the country. Read more about us in our terms and conditions.
This site is NOT authorized by Bristol -Myers-Squibb the manufacturers of Serzone and is not an Official Site of Serzone.
Serzone is a registered Trademark of Bristol -Myers-Squibb.
